Janux Therapeutics Inc.
(JANX)
undefined
undefined%
At close: undefined
61.11
0.02%
After-hours Dec 13, 2024, 05:19 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | 8.08M | 8.61M | 3.64M | - | - |
Cost of Revenue | 1.96M | 841.00K | 113.00K | 13.00K | 6.00K |
Gross Profit | 6.13M | 7.77M | 3.52M | -13.00K | -6.00K |
Operating Income | -72.98M | -67.09M | -32.93M | -4.84M | -3.77M |
Interest Income | 14.69M | 4.03M | 257.00K | 206.00K | 233.00K |
Pretax Income | -58.29M | -63.06M | -32.67M | -6.78M | -4.00M |
Net Income | -58.29M | -54.15M | -32.56M | -5.25M | -4.24M |
Selling & General & Admin | 26.14M | 22.26M | 10.33M | 1.80M | 772.00K |
Research & Development | 54.92M | 53.44M | 26.24M | 3.04M | 3.00M |
Other Expenses | - | 4.03M | 257.00K | -1.74M | - |
Operating Expenses | 81.06M | 75.70M | 36.57M | 4.84M | 3.77M |
Interest Expense | - | 4.03M | - | 206.00K | 233.00K |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 81.06M | 75.70M | 36.57M | 4.84M | 3.77M |
Income Tax | - | -8.90M | -113.00K | -1.53M | 233.00K |
Shares Outstanding (Basic) | 44.02M | 41.47M | 41.24M | 41.61M | 41.61M |
Shares Outstanding (Diluted) | 44.02M | 41.47M | 41.24M | 41.61M | 41.61M |
EPS (Basic) | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
EPS (Diluted) | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
EBITDA | -71.02M | -66.25M | -32.82M | -4.83M | -3.77M |
Depreciation & Amortization | 1.96M | 841.00K | 113.00K | 13.00K | 6.00K |